Tag: Cancer: Misc.
Immune-Related Adverse Events Up With Checkpoint Inhibitors
Most patients with cancer, autoimmune disease have improvement in events without discontinuing therapy
Few Immuno-Oncology Agents Reach ASCO Efficacy Thresholds
Durable survival, response rates rarely recognized as significant by current oncology value frameworks
December 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2017. This roundup includes...
ACOG Advocates Cascade Testing for Hereditary Gene Mutations
Ob-gyns should identify eligible patients, offer testing, and assist in decreasing barriers to testing
Out-of-Pocket Costs Correlate With Receipt of Cancer Care
Across cancers, higher costs tied to higher rates of oral prescription abandonment, delayed initiation
GERD Linked to Upper Aerodigestive Tract Cancers
In elderly, tied to higher odds of malignancy in larynx, hypopharynx, oropharynx, nasopharynx
Preoperative G-Tube Placement Associated With Cost Savings
In patients with aerodigestive tract cancers, pre- versus postoperative placement linked to lower costs
Findings Support Comprehensive Approach for Seniors With Cancer
Persistent symptoms, comorbidities, leisure-time physical activity, financial challenges deemed key factors
Early-Stage Cancer Diagnoses Up With ACA’s Medicaid Expansions
Both overall and early diagnosis of cancer increased in first year of expansions
Cancer Therapies May Trigger Aging Phenotypes in Survivors
Chemotherapies, radiation have direct effects on telomere length, epigenetic modifications, microRNA
